Serotonergic psychedelics are recently gaining a lot of attention as a potential treatment of several neuropsychiatric disorders. Broadband desynchronization of EEG activity and disconnection in humans have been repeatedly shown; however, translational data from animals are completely lacking. Therefore, the main aim of our study was to assess the effects of tryptamine and phenethylamine psychedelics (psilocin 4 mg/kg, LSD 0.2 mg/kg, mescaline 100 mg/kg, and DOB 5 mg/kg) on EEG in freely moving rats. A system consisting of 14 cortical EEG electrodes, co-registration of behavioral activity of animals with subsequent analysis only in segments corresponding to behavioral inactivity (resting-state-like EEG) was used in order to reach a high level of translational validity. Analyses of the mean power, topographic brain-mapping, and functional connectivity revealed that all of the psychedelics irrespective of the structural family induced overall and time-dependent global decrease/desynchronization of EEG activity and disconnection within 1-40 Hz. Major changes in activity were localized on the large areas of the frontal and sensorimotor cortex showing some subtle spatial patterns characterizing each substance. A rebound of occipital theta (4-8 Hz) activity was detected at later stages after treatment with mescaline and LSD. Connectivity analyses showed an overall decrease in global connectivity for both the components of cross-spectral and phase-lagged coherence. Since our results show almost identical effects to those known from human EEG/MEG studies, we conclude that our method has robust translational validity.

3rd Faculty of Medicine Charles University Prague Czechia

Department of Biomedical Technology Faculty of Biomedical Engineering Czech Technical University Prague Prague Czechia

National Institute of Mental Health Klecany Czechia

Zobrazit více v PubMed

Studerus E, Gamma A, Vollenweider FX. Psychometric evaluation of the altered states of consciousness rating scale (OAV) PLoS ONE. 2010;5:e12412. PubMed PMC

Shulgin, A. TiHKAL—tryptamines I have known and loved; the continuation. Berkeley, CA: Transform Press; 1997.

Araújo AM, Carvalho F, Bastos MDL, Guedes de Pinho P, Carvalho M. The hallucinogenic world of tryptamines: an updated review. Arch Toxicol. 2015;89:1151–1173. PubMed

Shulgin, A. PiHKAL—phenethylamines I have known and loved; a chemical love story. Berkeley, CA: Transform Press; 1991.

Halberstadt AL. Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behav Brain Res. 2015;277:99–120. PubMed PMC

Nichols DE. Psychedelics. Pharm Rev. 2016;68:264–355. PubMed PMC

Vollenweider FX, Kometer M. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Nature. 2010;11:642–651. PubMed

Baumeister D, Barnes G, Giaroli G, Tracy D. Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles. Ther Adv Psychopharmacol. 2014;4:156–69. PubMed PMC

Carhart-Harris RL, Bolstridge M, Rucker J, Day CMJ, Erritzoe D, Kaelen M, et al. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry. 2016;0366:11–13. PubMed

Atasoy S, Roseman L, Kaelen M, Kringelbach ML, Deco G, Carhart-Harris RL. Connectome-harmonic decomposition of human brain activity reveals dynamical repertoire re-organization under LSD. Sci Rep. 2017;7:1–18. PubMed PMC

Carhart-Harris RL, Leech R, Hellyer PJ, Shanahan M, Feilding A, Tagliazucchi E, et al. The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Front Hum Neurosci. 2014;8:20. PubMed PMC

Daws R, Timmerman C, Giribaldi B, Sexton J, Wall M, Erritzoe D, et al. Decreased brain modularity after psilocybin therapy for depression. 2021:1–19. 10.21203/rs.3.rs-513323/v1.

Yamamoto T, Ueki S. Behavioral effects of 2,5-dimethoxy-4-methylamphetamine (DOM) in rats and mice. Eur J Pharmacol. 1975;32:156–62. PubMed

Sipes TA, Geyer MA. Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology. 1994;33:441–8. PubMed

Krebs-Thomson K, Paulus MP, Geyer MA. Effects of hallucinogens on locomotor and investigatory activity and patterns: Influence of 5-HT(2A) and 5-HT(2C) receptors. Neuropsychopharmacology. 1998;18:339–51. PubMed

Ouagazzal A, Grottick AJ, Moreau J, Higgins GA. Effect of LSD on prepulse inhibition and spontaneous behavior in the rat. A pharmacological analysis and comparison between two rat strains. Neuropsychopharmacology. 2001;25:565–75. PubMed

Body S, Kheramin S, Ho MY, Miranda F, Bradshaw CM, Szabadi E. Effects of a 5-HT2 receptor agonist, DOI (2,5-dimethoxy-4-iodoamphetamine), and antagonist, ketanserin, on the performance of rats on a free-operant timing schedule. Behav Pharmacol. 2003;14:599–607. PubMed

Asgari K, Body S, Bak VK, Zhang ZQ, Rickard JF, Glennon JC, et al. Effects of 5-HT2A receptor stimulation on the discrimination of durations by rats. Behav Pharmacol. 2006;17:51–59. PubMed

Páleníček T, Balíková M, Bubeníková-Valešová V, Horáček J. Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose. Psychopharmacology. 2008;196:51–62. PubMed

Hasler F, Grimberg U, Benz MA, Huber T, Vollenweider FX. Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study. Psychopharmacology. 2004;172:145–56. PubMed

Fink M. EEG and human psychopharmacology. Annu Rev Pharmacol. 1969;9:241–58. PubMed

Riba J, Anderer P, Jané F, Saletu B, Barbanoj MJ. Effects of the South American psychoactive beverage Ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography. Neuropsychobiology. 2004;50:89–101. PubMed

Kometer M, Pokorny T, Seifritz E, Volleinweider FX. Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations. Psychopharmacology. 2015;232:3663–76. PubMed

Pallavicini C, Vilas MG, Villarreal M, Zamberlan F, Muthukumaraswamy S, Nutt D, et al. Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives. Neuroimage. 2019;200:281–91. PubMed

Timmermann C, Roseman L, Schartner M, Milliere R, Williams L, Erritzoe D, et al. Neural correlates of the DMT experience assessed with multivariate EEG. Sci Rep. 2019;9:1–13. PubMed PMC

Stuckey DE, Lawson R, Luna LE. EEG gamma coherence and other correlates of subjective reports during ayahuasca experiences. J Psychoact Drugs. 2005;37:163–78. PubMed

Don NS, McDonough BE, Moura G, Warren CA, Kawanishi K, Tomita H, et al. Effects of Ayahuasca on the human EEG. Phytomedicine. 1998;5:87–96. PubMed

Schenberg EE, Alexandre JFM, Filev R, Cravo AM, Sato JR, Muthukumaraswamy SD, et al. Acute biphasic effects of ayahuasca. PLoS ONE. 2015;10:1–27. PubMed PMC

Riba J, Anderer P, Morte A, Urbano G, Jané F, Saletu B, et al. Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers. Br J Clin Pharmacol. 2002;53:613–28. PubMed PMC

Muthukumaraswamy SD. High-frequency brain activity and muscle artifacts in MEG/EEG: a review and recommendations. Front Hum Neurosci. 2013;7:1–11. PubMed PMC

Muthukumaraswamy SD, Carhart-Harris RL, Moran RJ, Brookes MJ, Williams TM, Errtizoe D, et al. Broadband cortical desynchronization underlies the human psychedelic state. J Neurosci. 2013;33:15171–83. PubMed PMC

Vogt M, Gunn CG, Sawyer CH. Electroencephalographic effects of intraventricular 5-HT and LSD in the cat. Neurology. 1957;7:559–66. PubMed

Bradley PB, Elkes J. The effects of some drugs on the electrical activity of the brain. Brain. 1957;80:77–117. PubMed

Speck LB. Electroencephalographic changes in the rat with mescaline intoxication. J Pharmacol Exp Therapeut. 1958;122:201–206. PubMed

Adey RW, Bell FR, Dennis BJ. Effects of LSD-25, psilocybin, and psilocin on temporal lobe EEG patterns and learned behavior in the cat. Neurology. 1962;12:591–602. PubMed

Horovitz ZP, Mulroy MI, Waldron T, Leaf R. Behavioral and electroencephalographic effects of LSD. J Pharm Sci. 1965;54:108–10. PubMed

Celada P, Puig MV, Díaz-Mataix L, Artigas F. The hallucinogen DOI reduces low-frequency oscillations in rat prefrontal cortex: reversal by antipsychotic drugs. Biol Psychiatry. 2008;64:392–400. PubMed

Riga MS, Soria G, Tudela R, Artigas F, Celada P. The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs. Int J Neuropsychopharmacol. 2014;17:1269–82. PubMed

Wood J, Kim Y, Moghaddam B. Disruption of prefrontal cortex large scale neuronal activity by different classes of psychotomimetic drugs. J Neurosci. 2012;32:3022–31. PubMed PMC

Goda SA, Piasecka J, Olszewski M, Kasicki S, Hunt MJ. Serotonergic hallucinogens differentially modify gamma and high frequency oscillations in the rat nucleus accumbens. Psychopharmacology. 2013;228:271–82. PubMed PMC

Páleníček T, Fujáková M, Brunovský M, Horáček J, Gorman I, Balíková M, et al. Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats. Psychopharmacology. 2013;225:75–93. PubMed

Fujáková M, Páleníček T, Brunovský M, Gorman I, Tylš F, Kubešová A, et al. The effect of ((-)-2-oxa-4-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY379268), an mGlu2/3 receptor agonist, on EEG power spectra and coherence in ketamine model of psychosis. Pharmacol Biochem Behav. 2014;122:212–21. PubMed

Nichols DE. Hallucinogens. Pharmacol Ther. 2004;101:131–81. PubMed

Páleníček T, Hliňák Z, Bubeníková-Valešová V, Novák T, Horáček J. Sex differences in the effects of N,N-diethyllysergamide (LSD) on behavioural activity and prepulse inhibition. Prog Neuro-Psychopharmacology Biol Psychiatry. 2010;34:588–96. PubMed

Tylš F, Páleníček T, Kadeřábek L, Lipski M, Kubešová A, Horáček J. Sex differences and serotonergic mechanisms in the behavioural effects of psilocin. Behav Pharmacol. 2016;27:309–20. PubMed

Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Amsterdam: Academic Press/Elsevier Inc.; 2014.

Vejmola Č, Tylš F, Kadeřábek L, Lipski M, Páleníček T. Poster, Quantitative EEG study of serotonergic hallucinogens in rats—the relationship of brain activity and behavior. In: 29th ECNP Congress. Vienna: ECNP Congress; 2016, P.1.g.080., Vieta E.

Hansen IH, Agerskov C, Arvastson L, Bastlund JF, Sørensen H, Herrik KF. Pharmaco-electroencephalographic responses in the rat differ between active and inactive locomotor states. Eur J Neurosci. 2019;50:1948–71. PubMed PMC

Thatcher RW, Biver CJ, North DM. Quantitative EEG and the Frye and Daubert standards of admissibility. Clin EEG Neurosci. 2003;34:39–53. PubMed

Nolte G, Bai O, Wheaton L, Mari Z, Vorbach S, Hallett M. Identifying true brain interaction from EEG data using the imaginary part of coherency. Clin Neurophysiol. 2004;115:2292–307. PubMed

Stam CJ, Nolte G, Daffertshofer A. Phase lag index: assessment of functional connectivity from multi channel EEG and MEG with diminished bias from common sources. Hum Brain Mapp. 2007;28:1178–93. PubMed PMC

Andreou C, Faber PL, Leicht G, Schoettle D, Polomac N, Hanganu-Opatz IL, et al. Resting-state connectivity in the prodromal phase of schizophrenia: Insights from EEG microstates. Schizophr Res. 2014;152:513–20. PubMed

Thatcher RW. Coherence, phase differences, phase shift, and phase lock in EEG/ERP analyses. Dev Neuropsychol. 2012;37:476–96. PubMed

Erra RG, Velazquez JLP, Rosenblum M. Neural synchronization from the perspective of non-linear dynamics. Front Comput Neurosci. 2017;11:1–4. PubMed PMC

Buzsáki G, Logothetis N, Singer W. Scaling brain size, keeping timing: evolutionary preservation of brain rhythms. Neuron. 2013;80:751–64. PubMed PMC

John JA, Draper NR. An alternative family of transformations. J R Stat Soc. 1980;29:190–197.

Koopman PAR, Wouters PAWM, Krijzer FNC. Mean power spectra from pharmaco-electrocorticographic studies: Relative baseline correction and log transformation for a proper analysis of variance to assess drug effects. Neuropsychobiology. 1996;33:100–105. PubMed

Piorecká V, Krajča V, Tylš F, Páleníček T. Methods for animal brain mapping. Radioengineering. 2018;27:806–12.

Saito K, Toyo’oka T, Fukushima T, Kato M, Shirota O, Goda Y. Determination of psilocin in magic mushrooms and rat plasma by liquid chromatography with fluorimetry and electrospray ionization mass spectrometry. Anal Chim Acta. 2004;527:149–56.

Nakahara Y, Kikura R, Takahashi K, Foltz RL, Mieczkowski T. Detection of LSD and metabolite in rat hair and human hair. J Anal Toxicol. 1996;20:323–329. PubMed

Beránková K, Szkutová M, Balíková M. Distribution profile of 2,5-dimethoxy-4-bromoamphetamine (DOB) in rats after oral and subcutaneous doses. Forensic Sci Int. 2007;170:94–99. PubMed

Drinkenburg WHIM, Ruigt GSF, Ahnaou A. Pharmaco-EEG studies in animals: an overview of contemporary translational applications. Neuropsychobiology. 2016;72:151–64. PubMed

Young GA. Relationship between amphetamine-induced effects on EEG power spectra and motor activity in rats. Pharmacol Biochem Behav. 1988;30:489–92. PubMed

Ahnaou A, Huysmans H, Jacobs T, Drinkenburg WHIM. Cortical EEG oscillations and network connectivity as efficacy indices for assessing drugs with cognition enhancing potential. Neuropharmacology. 2014;86:362–77. PubMed

Marona-Lewicka D, Thisted RA, Nichols DE. Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis. Psychopharmacology. 2005;180:427–35. PubMed

Marona-Lewicka D, Nichols DE. Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action. Pharmacol Biochem Behav. 2007;87:453–61. PubMed

Marona-Lewicka D, Chemel BR, Nichols DE. Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI. Psychopharmacology. 2009;203:265–77. PubMed

Kropf W, Kuschinsky K, Krieglstein J. Apomorphine-induced alterations in cortical EEG activity of rats: involvement of D-1 and D-2 dopamine receptors. Naunyn Schmiedebergs Arch Pharmacol. 1989;340:718–25. PubMed

Hwan SJ, Ji YK, Sang HK, Lee MG. Role of dopamine receptors on electroencephalographic changes produced by repetitive apomorphine treatments in rats. Korean J Physiol Pharmacol. 2009;13:147–51. PubMed PMC

Nelson ME, Bryant SM, Aks SE. Emerging drugs of abuse. Dis-a-Mon. 2014;60:110–32. PubMed

Dimpfel W, Spüler M, Nichols DE. Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting DOM, DOI, DOB, MDMA, and MBDB by spectral analysis of brain field potentials in the freely moving rat (Tele-Stereo-EEG) Psychopharmacology. 1989;98:297–303. PubMed

Titeler M, Lyon RA, Davis KH, Glennon RA. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), A 5-HT2 agonist radioligand. Biochem Pharmacol. 1987;36:3265–71. PubMed

Rickli A, Moning OD, Hoener MC, Liechti ME. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens. Eur Neuropsychopharmacol. 2016;26:1327–37. PubMed

Puig MV, Watakabe A, Ushimaru M, Yamamori T, Kawaguchi Y. Serotonin modulates fast-spiking interneuron and synchronous activity in the rat prefrontal cortex through 5-HT1A and 5-HT2A receptors. J Neurosci. 2010;30:2211–22. PubMed PMC

Carhart-Harris RL, Kaelen M, Bolstridge M, Williams TM, Williams LT, Underwood R, et al. Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc Natl Acad Sci USA. 2016;46:1379–90. PubMed PMC

Kometer M, Schmidt A, Jäncke L, Vollenweider FX. Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations. J Neurosci. 2013;33:10544–51. PubMed PMC

Burn CC. What is it like to be a rat? Rat sensory perception and its implications for experimental design and rat welfare. Appl Anim Behav Sci. 2008;112:1–32.

Jiricek S, Koudelka V, Lacik J, Vejmola C, Kuratko D, Wójcik DK, et al. Electrical source imaging in freely moving rats: evaluation of twelve-electrode cortical EEG system. Front Neuroinform. 2021;14:68. PubMed PMC

Prefrontal electrophysiological biomarkers and mechanism-based drug effects in a rat model of alcohol addiction

Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats

Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in rats

Psilocybin-Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience